Product NDC: | 68382-130 |
Proprietary Name: | Mycophenolate Mofetil |
Non Proprietary Name: | Mycophenolate Mofetil |
Active Ingredient(s): | 250 mg/1 & nbsp; Mycophenolate Mofetil |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68382-130 |
Labeler Name: | Zydus Pharmaceuticals (USA) Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065433 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090504 |
Package NDC: | 68382-130-05 |
Package Description: | 500 CAPSULE in 1 BOTTLE (68382-130-05) |
NDC Code | 68382-130-05 |
Proprietary Name | Mycophenolate Mofetil |
Package Description | 500 CAPSULE in 1 BOTTLE (68382-130-05) |
Product NDC | 68382-130 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mycophenolate Mofetil |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20090504 |
Marketing Category Name | ANDA |
Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
Substance Name | MYCOPHENOLATE MOFETIL |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antimetabolite Immunosuppressant [EPC] |